Cytogenetic response to pipobroman in Philadelphia-positive chronic myeloid leukemia with thrombocythemic onset

Ann Hematol. 2005 Feb;84(2):127-8. doi: 10.1007/s00277-004-0947-7. Epub 2004 Sep 15.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Cytogenetic Analysis
  • Female
  • Fusion Proteins, bcr-abl / genetics
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Pipobroman / therapeutic use*
  • RNA, Messenger / analysis
  • Recurrence
  • Remission Induction / methods
  • Thrombocythemia, Essential / etiology*
  • Time Factors

Substances

  • Antineoplastic Agents, Alkylating
  • RNA, Messenger
  • Pipobroman
  • Fusion Proteins, bcr-abl